A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Item
http://www.wikidata.org/entity/Q34045764
The use of antidepressant and antipsychotic drugs in elderly epilepsy patients.Treatments for chronic psychosis.Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.Management of the behavioral and psychological symptoms of dementia.Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.Sleep and agitation in nursing home residents with and without dementia.Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil.Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease.How do family carers respond to behavioral and psychological symptoms of dementia?
P2860

A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Item
http://www.wikidata.org/entity/Q34045764
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A risk-benefit assessment of r ...... ological symptoms in dementia.
@ast
A risk-benefit assessment of r ...... ological symptoms in dementia.
@en
A risk-benefit assessment of r ...... ological symptoms in dementia.
@nl
type
label
A risk-benefit assessment of r ...... ological symptoms in dementia.
@ast
A risk-benefit assessment of r ...... ological symptoms in dementia.
@en
A risk-benefit assessment of r ...... ological symptoms in dementia.
@nl
prefLabel
A risk-benefit assessment of r ...... ological symptoms in dementia.
@ast
A risk-benefit assessment of r ...... ological symptoms in dementia.
@en
A risk-benefit assessment of r ...... ological symptoms in dementia.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
A risk-benefit assessment of r ...... ological symptoms in dementia.
@en
P2093
P2888
P304
P31
P356
10.2165/00002018-200023030-00002
P433
P478
P577
P6179
P698